Search Results 1811-1820 of 4043 for Solid
So, for example, with solid organ transplant patients, after three doses, the data suggests that maybe about 60 plus percent of them would be protected ...
... solid tumors curatively treated with no evidence of disease for > 2 years. Any active disease condition that would render the protocol treatment dangerous ...
Classification of alveolar RMS (ARMS) in the 2020 WHO Classification is the same as in the ICR and includes classic and solid variants. ERMS -Stage 4, group ...
Cornelius Thiels, D.O.. "The modern management of pancreas surgery often requires patients to be treated with multiple treatment modalities, including ...
... Solid Tumors version 1.1 (RECIST 1.1) after initial treatment. A Study to Evaluate Maximizing Anti-PD-1 Therapy By Monitoring T Cell Responses In Melanoma ...
... Solid Tumors version 1.1 (RECIST 1.1) after initial treatment. Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification ...
It is also used to treat mismatch repair deficient (dMMR) solid tumor that has returned or spread, and has progressed during or after treatment that did not ...
... solid tumors. Neoplasia.2015 Apr;17:(4):385-99. Shi J, Lew M, Zalupski MM, Roh MH, Kwon RS, Pang JC. Implication of suspicious cytology in endoscopic ...
Patients who have received a previous solid organ transplantation or hematopoietic stem cell transplantation. Patients who receive a multi-organ transplant ...
Recipient of solid organ or bone marrow transplants;; Currently on immunosuppressive therapy, including cancer chemotherapy;; Currently on medications for ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!